Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

IRAK-4: a new drug target in inflammation, sepsis, and autoimmunity.

IRAK-4: a new drug target in inflammation, sepsis, and autoimmunity. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • IRAK-4: a new drug target in inflammation, sepsis, and autoimmunity. Abstract Text:

    claudia wietekClaudia Wietek,luke a o'neillLuke A O'Neill,claudia wietekClaudia Wietek,luke a o'neillLuke A O'Neill,

    IRAK-4: a new drug target in inflammation, sepsis, and autoimmunity. Publishing Authors By Initials

    c wietekC Wietek,la o'neillLA O'Neill,c wietekC Wietek,la o'neillLA O'Neill,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    IRAK-4: a new drug target in inflammation, sepsis, and autoimmunity. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Molecular interventions

    VOLUME: 2

    Page Numbers: 212-5

    Journal Abbreviation: Mol. Interv.

    ISSN: 1534-0384

    DAY: 2

    MONTH: Jul

    YEAR: 2002

    IRAK-4: a new drug target in inflammation, sepsis, and autoimmunity. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101093789

    IRAK-4: a new drug target in inflammation, sepsis, and autoimmunity. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: IRAK-4: a new drug target in inflammation, sepsis, and autoimmunity. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for IRAK-4: a new drug target in inflammation, sepsis, and autoimmunity.

    AFFILIATION: Department of Biochemistry, Trinity College, Dublin 2, Ireland. wietec@tcd.ie

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Mol Interv

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    IRAK-4: a new drug target in inflammation, sepsis, and autoimmunity Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News